insulin glargine-yfgn
now available
Affordable, long-acting insulin glargine-yfgn in prefilled pens.
Available at the lowest list price in this market.
Not intended to represent an actual product
Get additional information for Consumers >
Civica insulin glargine-yfgn is now available in the United States. In California, the product will carry the CalRx® brand.
Civica insulin glargine-yfgn is available to pharmacies across the United States for $45 for a box of five prefilled pens, a significant discount in many cases to current prices.
Civica recommends that pharmacies set a maximum price for consumers — per our MaxRP™ policy — of no more than $55 per box, and that health plans set a consumer out-of-pocket price of zero dollars.
This pricing remains stable and transparent, unlike other manufacturers’ copay assistance programs that require registration and can change anytime.
Civica’s affordable insulin initiative
In 2022, Civica announced plans to manufacture and distribute insulins that, once approved, would be available to people with diabetes at significantly lower prices than insulins currently on the market.
The availability of affordable insulins benefits people with diabetes who have been forced to choose between life-sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out-of-pocket for their medications.
Civica, along with CivicaScript and the Civica Foundation, is collaborating on this effort with partners that represent nearly every corner of the diabetes ecosystem to advance this initiative.
Collaborations enable affordable insulin
The multi-year agreement between Civica and Biocon Biologics creates an arrangement where Biocon Biologics manufactures and supplies insulin glargine-yfgn to Civica, and Civica commercializes under Biocon Biologics’ existing marketing approval (a private label agreement).
Civica distributes, promotes and sells the medicine in the United States under a separate Civica label and packaging, and in California, the product carries the CalRx® brand.